Pain News and Research

Latest Pain News and Research

GlaxoSmithKline receives FDA approval for cervical cancer vaccine

GlaxoSmithKline announced today that the U.S. Food and Drug Administration (FDA) has approved CERVARIX® [Human papillomavirus bivalent (types 16 and 18) vaccine, recombinant] for the prevention of cervical pre-cancers and cervical cancer associated with oncogenic human papillomavirus (HPV) types 16 and 18 for use in girls and young women (aged 10-25).

19 Oct 2009

Robotically assisted minimally invasive bladder reconstructive surgery on children performed

For the first time, a surgical robot has been used to perform minimally invasive reconstructive surgery on five children whose bladder was dysfunctional because they were born with spina bifida [incomplete formation of the spine or spinal cord].

18 Oct 2009

AcelRx Pharmaceuticals’ programs to feature at upcoming annual meeting

AcelRx Pharmaceuticals, Inc. announced today that results of its Phase 1 studies evaluating the pharmacokinetics of its oral transmucosal NanoTab(TM) formulation of sufentanil will be featured in two oral presentations at the upcoming American Society of Anesthesiologists Annual Meeting in New Orleans.

15 Oct 2009

Delays contribute to unnecessary ER visits and additional imaging services in symptomatic gallstone treatment

Getting patients to the operating room more quickly could cut by half the amount paid for hospital treatment of painful gallstones, researchers reported today at the 2009 Clinical Congress of the American College of Surgeons.

15 Oct 2009

Policymakers urged to preserve access to advanced imaging in final health care reform legislation

Survivors and patients with cancers and heart disease, along with patient advocate organizations and physicians, today urged policymakers to enhance early diagnosis of deadly diseases by preserving access to advanced imaging, such as MRI and CT scans, in final health care reform legislation.

15 Oct 2009

Depression becomes more difficult to treat the longer it goes undiagnosed or undertreated

A new survey of 2,001 adults living with depression revealed that despite being diagnosed for an average of 12 years, many unknowingly took actions that could have sabotaged their chances of getting well. Furthermore, on average, it took about six years for respondents to seek diagnosis from a health care professional, suggesting these adults may have been coping with depression for as long as 18 years.

15 Oct 2009

Cobroxin OTC pain reliever is now available online

Nutra Pharma Corp., a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that its over-the-counter pain reliever, Cobroxin, is available for sale online at Cobroxin.com.

15 Oct 2009

Co-promotion agreement to promote Prosed DS to urologists and retail pharmacists

Timm Medical Technologies, Inc., a specialist Urology company, announced today its exclusive co-promotion agreement with Ferring Pharmaceuticals Inc., a Swiss-based biopharmaceutical company, for Prosed® DS (methenamine, phenyl salicylate, methylene blue, benzoic acid, hyoscyamine sulfate) in the United States.

15 Oct 2009

Foundation for Chiropractic Progress joins 92 national associations in support of World Spine Day

The Foundation for Chiropractic Progress (www.f4cp.com), a not-for-profit organization dedicated to increasing public awareness of the benefits of chiropractic, joins the 92 national associations that are currently members of the World Federation of Chiropractic in support of World Spine Day taking place on October 16, 2009.

15 Oct 2009

Shortage of general surgeons may be linked to higher rate of perforated appendix in rural areas

People who live in rural areas may run a greater risk of having perforated appendix than those in suburban and urban areas, according to a new study out of Dartmouth Medical School, Lebanon, NH. Not having enough general surgeons in rural regions may explain the disparity, according to researchers who presented their findings at the 95th annual Clinical Congress of the American College of Surgeons.

15 Oct 2009

Jazz Pharmaceuticals to present Phase III sodium oxybate trial data at ACR 2009 meetings

Jazz Pharmaceuticals, Inc. announced that data from the company's first Phase III clinical trial of sodium oxybate (JZP-6) for the treatment of fibromyalgia will be presented during the American College of Rheumatology 2009 Annual Meeting (ACR) in Philadelphia, Pennsylvania and also in November during the US Psychiatric and Mental Health Congress (US Psych Congress) in Las Vegas, Nevada.

15 Oct 2009

Progenics Pharmaceuticals and Wyeth Pharmaceuticals sign license agreement

Progenics Pharmaceuticals, Inc. today announced that it has entered into an agreement with Wyeth Pharmaceuticals, a division of Wyeth under which Progenics is regaining all worldwide rights to the RELISTOR® franchise from Wyeth Pharmaceuticals, which Progenics had previously licensed to Wyeth Pharmaceuticals.

14 Oct 2009

CeloNova BioSciences' Embozene Microspheres receives approval

CeloNova BioSciences, Inc. has received approval from its European regulatory body, the British Standards Institution, to expand the list of medical indications for which Embozene(TM) Microspheres may be used and to add a tenth size of the product.

14 Oct 2009

The Regence Foundation unveils signature philanthropic program to access quality palliative care

The Regence Foundation unveiled its signature philanthropic program today, Sojourns, to foster best practices, leadership and collaboration that help people with life-threatening and incurable illness to access quality palliative care in their own community. The Foundation also announced its first Sojourns grant to OHSU Doernbecher Children's Hospital for its Bridges pediatric palliative care program.

14 Oct 2009

Brain researcher finds how the epilepsy and pain drug works

A Duke University Medical Center researcher who spent years looking for the signals that prompt the brain to form new connections between neurons has found one that may explain precisely how a well-known drug for epilepsy and pain actually works.

14 Oct 2009

Telemedicine can optimize trauma care delivery

Telemedicine can help health care providers in rural areas stabilize and treat trauma victims when long distances or inclement weather prevents immediate transfer to an accredited trauma center.

14 Oct 2009

2009 American Cancer Society Pathfinder in Palliative Care awarded to James A. Block

James A. Block, M.D., president of J.A. Block Health Associates, will receive the inaugural 2009 American Cancer Society Pathfinder in Palliative Care Award, which recognizes individuals who have demonstrated innovation and ingenuity in their contributions to the advancement of the field of palliative care.

14 Oct 2009

Studies show that physiotherapy can help relieve symptoms of prostatitis

Prostatitis is no picnic. It is a urological condition which causes infection or inflammation of the prostate gland. It is a fairly common health concern, especially for men under 50 and can seriously affect quality of life including sexuality and intimate relationships. However, new research regarding the benefits of physiotherapy in treating prostititis is promising.

14 Oct 2009

Laser Spine Institute opens medical consultation facilities in Beverly Hills and Fort Lauderdale

After helping thousands of patients get their lives back through minimally invasive endoscopic spine surgery at facilities in Tampa, Scottsdale, and soon in Philadelphia, the Laser Spine Institute (LSI) announces the opening of their newest medical consultation facilities -- in Beverly Hills, Ca., and Fort Lauderdale, Fla., in October -- which aim to meet the growing demand for LSI's spinal procedures and provide greater convenience for local patients.

14 Oct 2009

Epeius Biotechnologies announces clinical study results of tumor-targeted genetic medicine

Epeius Biotechnologies Corporation today announced more stunning results of its pioneering clinical studies of Rexin-G, the world's first and, so far only, tumor-targeted genetic medicine to be validated in the clinic.

14 Oct 2009

Pain News and Research

Latest Pain News and Research

GlaxoSmithKline receives FDA approval for cervical cancer vaccine

Robotically assisted minimally invasive bladder reconstructive surgery on children performed

AcelRx Pharmaceuticals’ programs to feature at upcoming annual meeting

Delays contribute to unnecessary ER visits and additional imaging services in symptomatic gallstone treatment

Policymakers urged to preserve access to advanced imaging in final health care reform legislation

Depression becomes more difficult to treat the longer it goes undiagnosed or undertreated

Cobroxin OTC pain reliever is now available online

Co-promotion agreement to promote Prosed DS to urologists and retail pharmacists

Foundation for Chiropractic Progress joins 92 national associations in support of World Spine Day

Shortage of general surgeons may be linked to higher rate of perforated appendix in rural areas

Jazz Pharmaceuticals to present Phase III sodium oxybate trial data at ACR 2009 meetings

Progenics Pharmaceuticals and Wyeth Pharmaceuticals sign license agreement

CeloNova BioSciences' Embozene Microspheres receives approval

The Regence Foundation unveils signature philanthropic program to access quality palliative care

Brain researcher finds how the epilepsy and pain drug works

Telemedicine can optimize trauma care delivery

2009 American Cancer Society Pathfinder in Palliative Care awarded to James A. Block

Studies show that physiotherapy can help relieve symptoms of prostatitis

Laser Spine Institute opens medical consultation facilities in Beverly Hills and Fort Lauderdale

Epeius Biotechnologies announces clinical study results of tumor-targeted genetic medicine

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Pain News and Research

Latest Pain News and Research

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Newsletters you may be interested in